Latest Insider Transactions at Acumen Pharmaceuticals, Inc. (ABOS)
This section provides a real-time view of insider transactions for Acumen Pharmaceuticals, Inc. (ABOS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Acumen Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Acumen Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 12
2026
|
Daniel Joseph O Connell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,388
-0.9%
|
$5,388
$1.73 P/Share
|
|
Jan 12
2026
|
Derek M Meisner Chief Legal Officer & Corp Sec |
SELL
Open market or private sale
|
Direct |
8,548
-9.26%
|
$8,548
$1.71 P/Share
|
|
Jan 09
2026
|
Daniel Joseph O Connell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
12,941
-2.12%
|
$12,941
$1.76 P/Share
|
|
Jan 09
2026
|
Derek M Meisner Chief Legal Officer & Corp Sec |
SELL
Open market or private sale
|
Direct |
5,200
-5.33%
|
$5,200
$1.76 P/Share
|
|
Jan 08
2026
|
Daniel Joseph O Connell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,143
-1.31%
|
$8,143
$1.82 P/Share
|
|
Jan 08
2026
|
Derek M Meisner Chief Legal Officer & Corp Sec |
SELL
Open market or private sale
|
Direct |
36,911
-14.32%
|
$36,911
$1.82 P/Share
|
|
Jan 08
2026
|
Russell Barton Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,530
-2.78%
|
$3,530
$1.86 P/Share
|
|
Jan 08
2026
|
Matt Zuga CFO & Chief Business Officer |
SELL
Open market or private sale
|
Direct |
6,888
-3.18%
|
$6,888
$1.82 P/Share
|
|
Jan 08
2026
|
James J. Doherty President and CDO |
SELL
Open market or private sale
|
Direct |
6,467
-10.69%
|
$6,467
$1.82 P/Share
|
|
Jan 07
2026
|
Amy Schacterle Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
1,097
-12.47%
|
$1,097
$1.98 P/Share
|
|
Jan 07
2026
|
James J. Doherty President and CDO |
SELL
Open market or private sale
|
Direct |
1,700
-2.73%
|
$1,700
$1.99 P/Share
|
|
Jan 07
2026
|
Russell Barton Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,700
-1.32%
|
$1,700
$1.99 P/Share
|
|
Jan 07
2026
|
Derek M Meisner Chief Legal Officer & Corp Sec |
SELL
Open market or private sale
|
Direct |
11,770
-4.07%
|
$11,770
$1.99 P/Share
|
|
Jan 07
2026
|
Daniel Joseph O Connell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
37,755
-5.74%
|
$37,755
$1.99 P/Share
|
|
Jan 07
2026
|
Matt Zuga CFO & Chief Business Officer |
SELL
Open market or private sale
|
Direct |
5,805
-1.31%
|
$5,805
$2.0 P/Share
|
|
Jan 06
2026
|
Russell Barton Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,618
-2.74%
|
$3,618
$1.97 P/Share
|
|
Jan 06
2026
|
Derek M Meisner Chief Legal Officer & Corp Sec |
SELL
Open market or private sale
|
Direct |
10,898
-3.53%
|
$10,898
$1.97 P/Share
|
|
Jan 06
2026
|
Daniel Joseph O Connell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,102
-0.77%
|
$5,102
$1.97 P/Share
|
|
Jan 06
2026
|
Eric Siemers Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,834
-4.11%
|
$6,834
$1.97 P/Share
|
|
Jan 06
2026
|
Matt Zuga CFO & Chief Business Officer |
SELL
Open market or private sale
|
Direct |
5,100
-2.24%
|
$5,100
$1.97 P/Share
|
|
Jan 05
2026
|
Russell Barton Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,000
-2.94%
|
$4,000
$1.96 P/Share
|
|
Jan 05
2026
|
Derek M Meisner Chief Legal Officer & Corp Sec |
SELL
Open market or private sale
|
Direct |
4,000
-2.48%
|
$4,000
$1.96 P/Share
|
|
Jan 05
2026
|
Daniel Joseph O Connell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,649
-0.7%
|
$4,649
$1.97 P/Share
|
|
Jan 05
2026
|
Eric Siemers Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-2.35%
|
$4,000
$1.96 P/Share
|
|
Jan 05
2026
|
Matt Zuga CFO & Chief Business Officer |
SELL
Open market or private sale
|
Direct |
4,000
-1.73%
|
$4,000
$1.96 P/Share
|
|
Jun 04
2025
|
Ra Capital Management, L.P. |
BUY
Grant, award, or other acquisition
|
Indirect |
12,800
+50.0%
|
-
|
|
Jun 04
2025
|
Laura Stoppel Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,800
+50.0%
|
-
|
|
Jun 04
2025
|
Kimberlee C Drapkin Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,800
+50.0%
|
-
|
|
Jun 04
2025
|
Nathan B Fountain Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,800
+40.19%
|
-
|
|
Jun 04
2025
|
John A Stalfort Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,800
+6.47%
|
-
|
|
Jun 04
2025
|
Derrell Porter Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,800
+50.0%
|
-
|
|
Jun 04
2025
|
Jeffrey L. Ives Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,800
+50.0%
|
-
|
|
Jan 23
2025
|
Matt Zuga CFO & Chief Business Officer |
SELL
Open market or private sale
|
Direct |
28,902
-11.09%
|
$28,902
$1.72 P/Share
|
|
Jan 21
2025
|
Matt Zuga CFO & Chief Business Officer |
SELL
Open market or private sale
|
Direct |
4,364
-1.65%
|
$4,364
$1.6 P/Share
|
|
Jan 21
2025
|
Russell Barton Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,914
-2.1%
|
$2,914
$1.61 P/Share
|
|
Jan 21
2025
|
Derek M Meisner Chief Legal Officer & Corp Sec |
SELL
Open market or private sale
|
Direct |
3,418
-2.08%
|
$3,418
$1.59 P/Share
|
|
Jan 21
2025
|
Daniel Joseph O Connell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
12,619
-1.86%
|
$12,619
$1.59 P/Share
|
|
Jan 21
2025
|
Eric Siemers Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,219
-1.86%
|
$3,219
$1.59 P/Share
|
|
Jan 07
2025
|
Daniel Joseph O Connell Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
225,400
+24.89%
|
-
|
|
Jan 06
2025
|
James J. Doherty President and CDO |
BUY
Grant, award, or other acquisition
|
Direct |
62,600
+50.0%
|
-
|
|
Jan 06
2025
|
Amy Schacterle Chief Regulatory Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,800
+50.0%
|
-
|
|
Jan 06
2025
|
Russell Barton Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
49,800
+26.37%
|
-
|
|
Jan 06
2025
|
Derek M Meisner Chief Legal Officer & Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct |
66,800
+28.87%
|
-
|
|
Jan 06
2025
|
Matt Zuga CFO & Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
66,800
+20.13%
|
-
|
|
Jan 06
2025
|
Eric Siemers Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
66,800
+27.8%
|
-
|
|
Jan 03
2025
|
Daniel Joseph O Connell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
47,778
-9.51%
|
$47,778
$1.84 P/Share
|
|
Jan 03
2025
|
Russell Barton Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
7,636
-7.88%
|
$7,636
$1.86 P/Share
|
|
Jan 03
2025
|
Derek M Meisner Chief Legal Officer & Corp Sec |
SELL
Open market or private sale
|
Direct |
11,122
-10.22%
|
$11,122
$1.84 P/Share
|
|
Jan 03
2025
|
Matt Zuga CFO & Chief Business Officer |
SELL
Open market or private sale
|
Direct |
13,235
-6.26%
|
$13,235
$1.84 P/Share
|
|
Jan 03
2025
|
Eric Siemers Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,859
-9.24%
|
$10,859
$1.85 P/Share
|